XELJANZ
NDC 63539-029 · U.S. Pharmaceuticals
Generic nametofacitinib
Dosage formSOLUTION
RouteORAL
Active ingredient(s)TOFACITINIB CITRATE
Strength1 mg/mL
Pharmacologic classJanus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
Marketing categoryNDA
Packages
63539-029-02 — 1 BOTTLE in 1 CARTON (63539-029-02) / 240 mL in 1 BOTTLE (63539-029-01)
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
42799-970 — Tofacitinib, 50228-567 — Tofacitinib citrate, 51991-329 — Tofacitinib Citrate, 51991-963 — Tofacitinib Citrate, 59651-459 — TOFACITINIB, 59651-460 — TOFACITINIB, 59651-685 — TOFACITINIB, 60505-4858 — tofacitinib, 63539-012 — tofacitinib, 63539-016 — tofacitinib, 63539-501 — tofacitinib, 63539-502 — tofacitinib, 70069-841 — TOFACITINIB, 70069-842 — TOFACITINIB, 70095-008 — Tofacitinib, 70377-057 — Tofacitinib, 70710-1243 — tofacitinib, 70710-1353 — tofacitinib, 70710-1589 — tofacitinib, 70710-1727 — tofacitinib, +27 more